What is BVN stock?
BVN is the ticker symbol for Compañía de Minas Buenaventura S.A.A., the largest publicly traded precious metals mining company in Peru. Founded in 1953, the company is deeply involved in the exploration, mining, and processing of gold, silver, lead, zinc, and copper. It is listed on both the Lima Stock Exchange and the New York Stock Exchange (NYSE), making it a significant stock for investors interested in Latin American resource extraction. Buenaventura is known for its history of developing major mining projects, often in partnership with global mining giants. Because its performance is highly sensitive to the global prices of precious metals, BVN stock is often utilized by investors as a hedge against market volatility or as a way to gain direct exposure to the industrial demand for metals in the global commodities market. Investors should be aware of the geopolitical risks and the operational complexities associated with large-scale mining activities in the Andean region.
Related FAQs
Compañía de Minas Buenaventura S.A.A.
Compania de Minas Buenaventura stock prices are primarily dictated by global commodity markets, specifically prevailing spot and futures prices for precious metals like gold and silver.
Compañía de Minas Buenaventura SAA (NYSE: BVN) is evaluated by Wall Street analysts and financial advisory firms as a moderate holding, reflecting a mix of neutral to favorable consensus ratings.
Analysts tracking Compañía de Minas Buenaventura S.A.A. (BVN) maintain a mixed-to-favorable consensus rating, reflecting the dynamic operational and commodity-driven nature of the prominent Peruvian precious metals mining enterprise.
The price-to-earnings (P/E) ratio for Compañía de Minas Buenaventura (BVN) is dynamic and changes daily based on the stock's closing price and the company's trailing twelve-month earnings per share.
Compania de Minas Buenaventura S.A.A., identified by the ticker symbol BVN, is primarily listed and traded on the New York Stock Exchange.
Evaluating whether Biohaven Ltd. (traded under the ticker BHVN) is a favorable stock purchase involves assessing an investor's tolerance for clinical-stage biotechnology equities.
Compañía de Minas Buenaventura S.A.A., trading under the ticker BVN, operates as a prominent precious metals mining enterprise engaged in the exploration, extraction, and development of gold, silver, copper, and lead properties in Peru.